These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3738908)

  • 21. [A comparison between amlodipine and nifedipine retard in patients with essential arterial hypertension].
    Terrachini V; Canale C; Lonati A; Masperone MA; Bruzzone F; Malvestiti FM; Caponnetto S
    Clin Ter; 1992 Apr; 140(4):383-9. PubMed ID: 1534044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation.
    Grekas D; Dioudis C; Kalevrosoglou I; Papoulidou F; Goutsaridis N; Alivanis P; Tourkantonis A
    Clin Nephrol; 1995 Nov; 44(5):299-302. PubMed ID: 8605709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The bioavailability and pharmacokinetics of slow release nifedipine during chronic dosing in volunteers.
    Debbas NM; Jackson SH; Shah K; Abrams SM; Johnston A; Turner P
    Br J Clin Pharmacol; 1986 Apr; 21(4):385-8. PubMed ID: 3707812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind comparison of amlodipine and nifedipine retard in the treatment of mild to moderate hypertension.
    Lorimer AR; Anderson JA; Laher MS; Davies J; Lazarus JH; Taylor SH; Sanghera S
    J Hum Hypertens; 1994 Jan; 8(1):65-8. PubMed ID: 8151609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic effects of long-term treatments with nifedipine-retard and captopril in young hypertensive patients.
    Masuo K; Mikami H; Ogihara T; Tuck ML
    Am J Hypertens; 1997 Jun; 10(6):600-10. PubMed ID: 9194505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerance of nifedipine retard vs acebutolol in patients with essential hypertension treated for 26 weeks.
    Chamiec T; Zaleska T; Kłoś J; Pietrzykowska H; Bednarz B; Ceremuzyński L
    Mater Med Pol; 1989; 21(1):49-52. PubMed ID: 2634218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of blood pressure in hypertensive patients with felodipine extended release or nifedipine retard.
    Littler WA
    Br J Clin Pharmacol; 1990 Dec; 30(6):871-8. PubMed ID: 2288833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of slow release nifedipine tablets in patients with essential hypertension.
    Imai Y; Abe K; Munakata M; Sasaki S; Minami N; Sakuma H; Hashimoto J; Watanabe N; Sakuma M; Sekino H
    Arzneimittelforschung; 1992 Dec; 42(12):1434-8. PubMed ID: 1288507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nifedipine retard in the treatment of hypertension. A study using ambulatory blood pressure recordings.
    Hwang YS
    Clin Ther; 1990; 12(6):503-12. PubMed ID: 2289219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the efficacy of slow-release nifedipine in systemic hypertension by ambulatory intraarterial blood pressure monitoring.
    Bonaduce D; Canonico V; Mazza F; Nicolino A; Ferrara N; Chiariello M; Condorelli M
    J Cardiovasc Pharmacol; 1985; 7(1):145-51. PubMed ID: 2580135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nifedipine in the treatment of hypertension.
    Brennan F; Flanagan M; Blake S; Cannon P
    Eur J Clin Pharmacol; 1983; 25(6):713-5. PubMed ID: 6363097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The combination of nifedipine and a low sodium diet with potassium supplement in the therapy of essential arterial hypertension].
    Digiesi V; Parigi P
    Minerva Med; 1987 Oct; 78(19):1427-31. PubMed ID: 3670686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet.
    Aellig WH; Narjes HH; Nüesch E; Oertle RJ; Devos JE; Pacha W
    Eur J Clin Pharmacol; 1981; 20(3):179-83. PubMed ID: 7286035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of nifedipine.
    Pasanisi F; Meredith PA; Reid JL
    Int J Clin Pharmacol Res; 1985; 5(1):63-6. PubMed ID: 3997314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Assessment of the efficacy and tolerance of delayed-action nifedipine as the monotherapy or in combination with metoprolol in patients with arterial hypertension].
    Isaĭkina OIu; Gorbunov VM; Andreeva GF; Dmitrieva NA; Martsevich SIu
    Ter Arkh; 2003; 75(12):39-43. PubMed ID: 14959468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the antihypertensive effect of capsule and tablet forms of nifedipine in moderate hypertension].
    Thibonnier M; Sassano P; Corvol P
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():25-8. PubMed ID: 3937501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of buccoadhesive formulations and sublingual capsules of nifedipine.
    Save T; Shah MU; Ghamande AR; Venkitachalam P
    J Pharm Pharmacol; 1994 Mar; 46(3):192-5. PubMed ID: 8027926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nifedipine kinetics and dynamics in hypertensive patients: a new approach.
    Akopov SE; Sarkissian MA; Grigorian GS; Panossian AG
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):317-20. PubMed ID: 7921534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.